As we look back at April’s successful INTERPHEX exhibition and conference in New York City, it’s clear that while pharma faces current market and regulatory challenges, the industry also is focused on key strategies for the future. From a new multi-dose dry powder inhaler from CSP Technologies to the introduction of self-injectors
for patients with dexterity issues, personalized
approaches to medicine delivery were common themes
among many exhibitors at the show.
Along those lines, the growing trend toward the
development of highly targeted pharmaceuticals played
a role among exhibitors that are keen on serving the
needs of newer and smaller R&D facilities.
They may have much smaller footprints than the
big players, but still need to meet the regulatory and
other requirements of the large players. To that end,
technology companies like MG America were busy
featuring new equipment options developed in more
compact and flexible formats.
In addition, there was no shortage of new
automation options designed for drug development
and manufacturing at facilities large and small.
Among the exhibitors highlighting the latest solutions
were the automation units of Emerson and Rockwell,
Honeywell Process Solutions and
Also present on the show floor
were several new cleanroom
solutions, vastly improved data
collection strategies, security
initiatives designed to protect proprietary data, and
numerous software and packaging options aimed at
implementing successful serialization programs to
meet regulatory requirements.
One rather surprising takeaway from the show was
the often-repeated observation among serialization
technology suppliers that a large number of companies
in the pharma community still appear to be well
behind in efforts to meet the upcoming deadlines. It
may not be too late, but the message was clear that
those companies seriously should consider prioritizing
serialization now to avoid facing fines toward year end.
As for the show itself, attendance was strong at
INTERPHEX Live! and other conference sessions,
and booth traffic appeared to be vibrant.
Will that enthusiasm continue through to next year?
Stay tuned to PharmPro.com for the daily pulse of the
market as we work our way toward INTERPHEX
2019, scheduled for next April 2-4, in New York City.
— Mike Botta
Follow Pharmaceutical Processing Online!
Pharmaceutical Processing® (ISSN #1049-9156, USPS #001-314), is published seven times a
year. Bi-monthly in Jan/Feb, Apr/May, Jul/Aug, Sep/Oct, Nov/Dec monthly in Mar & Jun by Advantage
Business Media, 100 Enterprise Drive, Suite 600, Rockaway, NJ 07866. No part of this publication
may be reproduced in any form without prior written permission of the publisher. Opinions expressed in
articles are those of the authors and do not necessarily reflect those of Advantage Business Media.
Periodicals Mail postage paid at Rockaway, NJ 07866 and at additional mailing offices.
POSTMASTER: Send address changes/cancellations to Pharmaceutical Processing, 100 Enterprise
Drive, Suite 600, Rockaway, NJ 07866-0912, email: ABM_return@advantagemedia.com. Publications
Mail Agreement No. 41336030. Return undeliverable Canadian addresses to: Imex/Pitney Bowes, P.O.
Box 1632, Windsor Ontario N9A 7C9.
Subscriptions are free to qualified individuals.
Printed in USA: Every attempt is made to ensure the accuracy of the information contained herein,
however Advantage Business Media and its employees cannot accept responsibility for the correctness
of information supplied, advertisements, or opinions expressed. Copyright ©2018 Advantage Business
Media. All rights reserved.
Michael J. Beier,
Senior Vice President of Operations
TITAN PHARMACEUTICALS, INC.
Dr. James V. Blackwell, PhD, Consultant
BIOPROCESS TECHNOLOGY CONSULTANTS,
Ronald C. Branning,
Vice President Global Quality
Robert F. Dream, Vice President
H.D.R. COMPANY LTD.
Johanna Carmel Egan,
VGP Project Management
Girish Malhotra, President
Allan F. Pfitzenmaier, President
VECTECH PHARMA CONSULTANTS INC.
Susan Polizzotto, Manager,
R&D QA GMP Compliance
US SANOFI PASTEUR
Sr. Dir. Global Engineering
Richard G. Whitfield, Senior Director
Patrick Wong, Director of Global Engineering
BRISTOL-MYERS SQUIBB (BMS)
For subscription related matters please
contact us at:
Setting the Stage for 2019